These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 33526874)

  • 1. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Williamson SR; Gill AJ; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Hes O
    Mod Pathol; 2021 Jun; 34(6):1167-1184. PubMed ID: 33526874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney Tumors: New and Emerging Kidney Tumor Entities.
    Siadat F; Mansoor M; Hes O; Trpkov K
    Clin Lab Med; 2023 Jun; 43(2):275-298. PubMed ID: 37169446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Tumors: New and Emerging Kidney Tumor Entities.
    Siadat F; Mansoor M; Hes O; Trpkov K
    Surg Pathol Clin; 2022 Dec; 15(4):713-728. PubMed ID: 36344185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and emerging renal entities: a perspective post-WHO 2016 classification.
    Trpkov K; Hes O
    Histopathology; 2019 Jan; 74(1):31-59. PubMed ID: 30565301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
    Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex.
    Lerma LA; Schade GR; Tretiakova MS
    Hum Pathol; 2021 Oct; 116():1-11. PubMed ID: 34153307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification.
    Siadat F; Trpkov K
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.
    Srigley JR; Delahunt B; Eble JN; Egevad L; Epstein JI; Grignon D; Hes O; Moch H; Montironi R; Tickoo SK; Zhou M; Argani P;
    Am J Surg Pathol; 2013 Oct; 37(10):1469-89. PubMed ID: 24025519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do we need an updated classification of oncocytic renal tumors? : Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities.
    Hes O; Trpkov K
    Mod Pathol; 2022 Sep; 35(9):1140-1150. PubMed ID: 35273336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights in the new WHO classification of adult renal tumors.
    Hes O; Michalová K; Pivovarčíková K
    Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification.
    Udager AM; Mehra R
    Arch Pathol Lab Med; 2016 Oct; 140(10):1026-37. PubMed ID: 27684973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving classification of renal cell neoplasia.
    Delahunt B; Srigley JR
    Semin Diagn Pathol; 2015 Mar; 32(2):90-102. PubMed ID: 25753529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Provisional renal cell carcinoma subsets following the 2016 WHO classification].
    Jenei A; Hes O; Kuthi L
    Orv Hetil; 2020 Jan; 161(3):83-94. PubMed ID: 31928058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia 2012].
    Hes O
    Cesk Patol; 2014; 50(4):137-41. PubMed ID: 25418900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in renal neoplasia: recommendations from the 2012 International Society of Urological Pathology Consensus Conference.
    Delahunt B; Srigley JR; Montironi R; Egevad L
    Urology; 2014 May; 83(5):969-74. PubMed ID: 24661331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].
    Kristiansen G; Delahunt B; Srigley JR; Lüders C; Lunkenheimer JM; Gevensleben H; Thiesler T; Montironi R; Egevad L
    Pathologe; 2015 May; 36(3):310-6. PubMed ID: 25398389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Cell Carcinoma With Fibromyomatous Stroma-The Whole Story.
    Shah RB
    Adv Anat Pathol; 2022 May; 29(3):168-177. PubMed ID: 35249990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
    Lobo J; Ohashi R; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tickoo SK; Tsuzuki T; Turajlic S; Zhou M; Srigley JR; Moch H
    Histopathology; 2022 Oct; 81(4):426-438. PubMed ID: 35596618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: further support for the newly proposed entity.
    Wang XT; Xia QY; Fang R; Zhang RS; Ye SB; Li R; Wang X; Lu ZF; Ma HH; Zhou XJ; He HY; Zhao M; Rao Q
    Hum Pathol; 2022 May; 123():102-112. PubMed ID: 35192800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
    Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
    Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.